Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 The effects of bradykinin (0.2, 0.6, 2.0 µg/min), acetylcholine (ACh) (30 µg/min) and papaverine (PA) (12 mg) on net tissue plasminogen activator (tPA) release in the angiotensin-converting enzyme inhibitor group (open box) and the nonangiotensin-converting enzyme inhibitor group (closed circle). *p < 0.05 versus baseline.
|
